Quest Laboratories Stock Screener | Share Price & Fundamental Analysis
QUESTLAB
Pharmaceuticals
Screen Quest Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹180.42 Cr.
P/E Ratio (TTM)
15.00
EPS (TTM)
₹8.28
Dividend Yield
-
Debt to Equity
0.32
52W High
-
52W Low
-
Operating Margin
16.00%
Profit Margin
11.97%
Revenue (TTM)
₹117.00
EBITDA
₹19.00
Net Income
₹14.00
Total Assets
₹122.00
Total Equity
₹82.00
Quest Laboratories Share Price History - Stock Screener Chart
Screen QUESTLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Quest Laboratories Company Profile - Fundamental Screener
Screen Quest Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for QUESTLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0TNW01017
Quest Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen QUESTLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 122 | 61 | 47 | 35 | 18 |
| Current Assets | 107 | 50 | 34 | 27 | 12 |
| Fixed Assets | 12 | 10 | 10 | 7 | 6 |
| Liabilities | |||||
| Total Liabilities | 122 | 61 | 47 | 35 | 18 |
| Current Liabilities | 3 | 2 | 3 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 82 | 29 | 15 | 10 | 6 |
| Share Capital | 16 | 12 | 1 | 1 | 1 |
| Reserves & Surplus | 65 | 17 | 14 | 9 | 5 |
Screen QUESTLAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
| Revenue | 117 | 108 | 83 | 62 | 60 | 30 |
| Expenses | 98 | 88 | 67 | 54 | 53 | 29 |
| EBITDA | 19 | 20 | 16 | 8 | 7 | 2 |
| Operating Profit % | 16.00% | 15.00% | 19.00% | 13.00% | 11.00% | 5.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 0 |
| Interest | 2 | 1 | 1 | 1 | 0 | 0 |
| Profit Before Tax | 17 | 19 | 14 | 7 | 6 | 1 |
| Tax | 2 | 5 | 4 | 2 | 2 | 0 |
| Net Profit | 14 | 14 | 10 | 5 | 4 | 1 |
| EPS | 8.60 | 8.28 | 6.16 | 46.76 | 38.05 | 6.07 |
Quest Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen QUESTLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | -23 | 3 | 4 | 4 | 1 |
| Investing Activities | -44 | -5 | -4 | -2 | -1 |
| Financing Activities | 67 | 2 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 1 | 0 |
Screen QUESTLAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Sept | 2024-Mar | 2024-May |
|---|---|---|---|---|
| Promoter Holding | 66.21% | 66.78% | 90.36% | 90.36% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.07% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.35% | 25.50% | 0.00% | 0.00% |
| Other Holding | 9.37% | 7.72% | 9.64% | 9.64% |
| Shareholder Count | 1,001 | 1,084 | 20 | 23 |
Quest Laboratories Dividend Screener - Share Yield Analysis
Screen QUESTLAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Quest Laboratories Index Membership - Market Screener Classification
Screen QUESTLAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Quest Laboratories Market Events Screener - Corporate Actions
Screen QUESTLAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 0.24% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 3.02% |
| 2025-07-24 | 2025-07-24 | Quarterly Result Announcement | NA | 15.92% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -1.43% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 5.97% |
Quest Laboratories Competitors Screener - Peer Comparison
Screen QUESTLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,614 | 39.35 | 54,729 | 9.71% | 10,980 | 38.94 |
| Divis Laboratories | 169,701 | 68.64 | 9,712 | 18.67% | 2,191 | 47.61 |
| Torrent Pharmaceuticals | 130,301 | 60.42 | 11,539 | 6.99% | 1,911 | 63.27 |
| Cipla | 122,079 | 22.17 | 28,410 | 7.12% | 5,291 | 50.85 |
| Dr Reddys Laboratories | 106,115 | 18.42 | 33,741 | 16.73% | 5,725 | 53.02 |
| Lupin | 96,362 | 21.87 | 22,910 | 13.74% | 3,306 | 57.47 |
| Zydus Life Science | 92,005 | 18.03 | 23,511 | 18.55% | 4,615 | 43.59 |
| Mankind Pharma | 90,673 | 50.11 | 12,744 | 20.90% | 2,007 | 49.10 |
| Aurobindo Pharma | 68,709 | 20.16 | 32,346 | 9.43% | 3,484 | 45.26 |
| Alkem Laboratories | 65,838 | 26.89 | 13,458 | 3.70% | 2,216 | 41.76 |
Quest Laboratories Company Announcements - News Screener
Screen QUESTLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.